Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

11.09 -1.43 (-11.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125,587
Open 12.44
Bid (Size) 11.00 (3)
Ask (Size) 18.00 (2)
Prev. Close 12.52
Today's Range 11.09 - 12.95
52wk Range 6.560 - 30.38
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Exscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy Volunteers
 
Via Benzinga
Exscientia Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
From Exscientia plc
Via Business Wire

Performance

YTD
-45.40%
-45.40%
1 Month
-5.78%
-5.78%
3 Month
-17.91%
-17.91%
6 Month
-42.12%
-42.12%
1 Year
-59.08%
-59.08%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Exscientia to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
From Exscientia
Via Business Wire
83 Biggest Movers From Yesterday
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
Exscientia Business Update for First Quarter 2022
From Exscientia plc
Via Business Wire
Earnings Scheduled For May 25, 2022
Via Benzinga
Exscientia to Report First Quarter 2022 Financial Results on May 25, 2022
From Exscientia
Via Business Wire
Exscientia to Present at the BofA Securities 2022 Healthcare Conference
From Exscientia
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Exscientia Presents Three Posters Demonstrating Potential of Precision Medicine Platform in Drug Discovery at the American Association of Cancer Research Annual Meeting 2022
From Exscientia plc
Via Business Wire
Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer
From Exscientia
Via Business Wire
Exscientia Business Update for Fourth Quarter and Full Year 2021
From Exscientia plc
Via Business Wire
Earnings Scheduled For March 23, 2022
Via Benzinga
Exscientia to Report Fourth Quarter and Year End 2021 Financial Results on March 23, 2022
From Exscientia
Via Business Wire
Exscientia to Present at Upcoming Investor Conferences in March
From Exscientia
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
"Our Mission Is To Eliminate Cancer" – Here's How This Company Is Using AI In An Attempt To Save Lives
Via Benzinga
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
From Exscientia
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines
From Exscientia
Via Business Wire
Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
From Exscientia
Via Business Wire
Exscientia Business Update for Third Quarter 2021
From Exscientia
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.